RU2007118385A - Контрастные агенты для направлений доставки во внеклеточный матрикс - Google Patents

Контрастные агенты для направлений доставки во внеклеточный матрикс Download PDF

Info

Publication number
RU2007118385A
RU2007118385A RU2007118385/04A RU2007118385A RU2007118385A RU 2007118385 A RU2007118385 A RU 2007118385A RU 2007118385/04 A RU2007118385/04 A RU 2007118385/04A RU 2007118385 A RU2007118385 A RU 2007118385A RU 2007118385 A RU2007118385 A RU 2007118385A
Authority
RU
Russia
Prior art keywords
contrast agent
amino acid
agent according
formula
group
Prior art date
Application number
RU2007118385/04A
Other languages
English (en)
Russian (ru)
Inventor
Дагфинн ЛЕВХАУГ (NO)
Дагфинн ЛЕВХАУГ
Мортен ЭРИКСЕН (NO)
Мортен ЭРИКСЕН
Хеге Б. ФЬЕРДИНГСТАД (NO)
Хеге Б. ФЬЕРДИНГСТАД
Эндрю ХИЛИ (NO)
Эндрю ХИЛИ
Original Assignee
Джи-И Хелткер АС (NO)
Джи-И Хелткер АС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джи-И Хелткер АС (NO), Джи-И Хелткер АС filed Critical Джи-И Хелткер АС (NO)
Publication of RU2007118385A publication Critical patent/RU2007118385A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Steroid Compounds (AREA)
RU2007118385/04A 2004-11-22 2005-11-21 Контрастные агенты для направлений доставки во внеклеточный матрикс RU2007118385A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO200745081 2004-11-22
NO20045081 2004-11-22

Publications (1)

Publication Number Publication Date
RU2007118385A true RU2007118385A (ru) 2008-12-27

Family

ID=36182407

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007118385/04A RU2007118385A (ru) 2004-11-22 2005-11-21 Контрастные агенты для направлений доставки во внеклеточный матрикс

Country Status (17)

Country Link
US (1) US8182790B2 (https=)
EP (2) EP2243496A3 (https=)
JP (2) JP5116480B2 (https=)
KR (1) KR20070091609A (https=)
CN (1) CN101107016B (https=)
AT (1) ATE494913T1 (https=)
AU (1) AU2005307195A1 (https=)
BR (1) BRPI0518328A2 (https=)
CA (1) CA2586621A1 (https=)
DE (1) DE602005025911D1 (https=)
ES (1) ES2358745T3 (https=)
IL (1) IL182898A0 (https=)
MX (1) MX2007006050A (https=)
NO (1) NO20073039L (https=)
RU (1) RU2007118385A (https=)
WO (1) WO2006054904A2 (https=)
ZA (1) ZA200705043B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0610395D0 (en) * 2006-05-25 2006-07-05 Ge Healthcare Ltd Novel imaging agents
EP2056886A2 (en) * 2006-08-28 2009-05-13 GE Healthcare Limited 68ga-labeled peptide-based radiopharmaceuticals
JP2008266194A (ja) * 2007-04-19 2008-11-06 Hiroshi Tanaka 分子プローブの原料として有用な新規有機化合物
GB0722650D0 (en) * 2007-11-19 2007-12-27 Ge Healthcare Ltd Novel imaging method
JP5604305B2 (ja) 2007-12-13 2014-10-08 アンセルム（アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） 線維症の非侵襲性の特異的イメージングのための、ポリペプチド、環状ポリペプチドおよびそれを含む医薬
US8815214B2 (en) * 2008-01-18 2014-08-26 Visen Medical, Inc. Fluorescent imaging agents
CN102088991A (zh) 2008-05-13 2011-06-08 堪萨斯大学 金属提取肽标签和相关方法
GB0814722D0 (en) * 2008-08-12 2008-09-17 Ge Healthcare Ltd Treatment monitoring
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
KR100991716B1 (ko) * 2009-10-22 2010-11-04 경북대학교 산학협력단 광학영상 조영제, 그 용도 및 장치
CN102504603B (zh) * 2011-10-20 2014-01-29 中国海洋大学 一种多聚物与生物染色剂的偶合物及其制备方法和用途
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
WO2015085005A1 (en) * 2013-12-03 2015-06-11 The General Hospital Corporation Molecular imaging probes
CN117623996B (zh) * 2022-08-10 2025-07-22 中国药科大学 一种二价keap1-nrf2抑制剂、制备方法及其医药用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4615876A (en) * 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4687659A (en) 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US5268486A (en) 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US6048982A (en) 1986-04-18 2000-04-11 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
ATE145337T1 (de) 1988-05-02 1996-12-15 Phanos Tech Inc Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
GB8903022D0 (en) * 1989-02-10 1989-03-30 Celltech Ltd Chemical compounds
EP0643706A1 (en) 1991-11-27 1995-03-22 Zynaxis Inc. Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
DE69735901T2 (de) 1996-10-28 2007-05-10 Ge Healthcare As Verbesseringen an oder in verbindung mit diagnostischen/therapeutischen mitteln
ATE314097T1 (de) 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
JP2001509796A (ja) * 1997-01-29 2001-07-24 ニユコメド・イメージング・アクシエセルカペト 重合体
EP1037947B1 (en) 1997-07-28 2003-09-10 Amersham plc Cyanine dyes
US5942637A (en) * 1998-03-30 1999-08-24 North Dakota State University Research Foundation Compounds containing tetradecachlorocyclohexasilane dianion
US6852318B1 (en) * 1998-05-08 2005-02-08 The Regents Of The University Of California Methods for detecting and inhibiting angiogenesis
WO1999058139A2 (en) * 1998-05-08 1999-11-18 The Regents Of The University Of California Methods for detecting and inhibiting angiogenesis
JP2000095758A (ja) * 1998-09-18 2000-04-04 Schering Ag 近赤外蛍光造影剤および蛍光造影方法
US6230777B1 (en) 1999-02-04 2001-05-15 Midmac Systems, Inc. Filter forming and joining apparatus
CA2405469C (en) * 2000-04-12 2012-03-20 Amersham Health As Integrin binding peptide derivatives
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
EP1337278A2 (en) * 2000-11-27 2003-08-27 Bristol-Myers Squibb Medical Imaging, Inc. Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
BRPI0210886B8 (pt) * 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
GB0116815D0 (en) 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
GB0206750D0 (en) 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
JP2006510576A (ja) 2002-06-17 2006-03-30 カルテラ、アクチボラグ アテローム性動脈硬化症のプラーク形成の進行を防止するためのインテグリンα１０鎖の方法および使用
US7063158B2 (en) 2003-06-16 2006-06-20 Deepwater Technologies, Inc. Bottom tensioned offshore oil well production riser
NO20033115D0 (no) * 2003-07-08 2003-07-08 Amersham Health As Peptid-baserte forbindelser
GB0317815D0 (en) 2003-07-30 2003-09-03 Amersham Health As Imaging agents
WO2005019247A2 (en) 2003-08-15 2005-03-03 Board Of Regents, The University Of Texas System Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
JP2007512321A (ja) * 2003-11-24 2007-05-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
ATE447417T1 (de) * 2004-03-04 2009-11-15 Ge Healthcare As Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie
RU2393167C2 (ru) * 2004-06-16 2010-06-27 Джи-И Хелткер АС Пептидные соединения
JP5280682B2 (ja) * 2004-06-16 2013-09-04 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチド系化合物

Also Published As

Publication number Publication date
EP1814598A2 (en) 2007-08-08
EP2243496A2 (en) 2010-10-27
MX2007006050A (es) 2007-11-14
JP5116480B2 (ja) 2013-01-09
EP1814598B1 (en) 2011-01-12
WO2006054904A2 (en) 2006-05-26
NO20073039L (no) 2007-08-16
JP2008520658A (ja) 2008-06-19
US8182790B2 (en) 2012-05-22
ATE494913T1 (de) 2011-01-15
KR20070091609A (ko) 2007-09-11
IL182898A0 (en) 2007-08-19
EP2243496A3 (en) 2012-12-26
ZA200705043B (en) 2008-09-25
CA2586621A1 (en) 2006-05-26
BRPI0518328A2 (pt) 2008-11-11
DE602005025911D1 (de) 2011-02-24
US20090208412A1 (en) 2009-08-20
WO2006054904A3 (en) 2007-04-05
JP2012207027A (ja) 2012-10-25
ES2358745T3 (es) 2011-05-13
AU2005307195A1 (en) 2006-05-26
CN101107016A (zh) 2008-01-16
CN101107016B (zh) 2011-11-16

Similar Documents

Publication Publication Date Title
TW449482B (en) Radiolabeled peptides for diagnosis and therapy
RU2003137593A (ru) Соединения на основе пептидов для направленной доставки к рецепторам интегринов
RU2007118385A (ru) Контрастные агенты для направлений доставки во внеклеточный матрикс
Bandari et al. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN (7-14) NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer
ES2336780T3 (es) Agentes de formacion de imagenes dirigidos al receptor de folato.
JPH07506592A (ja) 造影用のテクネチウム‐９９ｍ標識ペプチド
US20110250144A1 (en) Rgd-containing peptidomimetics and uses thereof
CA2405469A1 (en) Integrin binding peptide derivatives
JP2003531835A5 (https=)
US20100015058A1 (en) Radiolabeled bbn-rgd heterodimers for cancer targeting
PT759786E (pt) Conjugados péptido-quelato metálico que se ligam a somatostatina
RU2006144279A (ru) Пептидные соединения
CN102316903A (zh) Pdgf-rbeta结合剂
JP2008504237A5 (https=)
US9259496B2 (en) Technetium labelled peptides
JP2008520658A5 (https=)
JP2020522557A (ja) 診断及び治療のための、改善された薬物動態及びコレシストキニン−２受容体（ｃｃｋ２ｒ）への標的化
RU2013113677A (ru) Визуализирующие апоптоз агенты на основе лантибиотических пептидов
RU2013122649A (ru) Способ радиоактивного коньюгирования
Zheng et al. Comparison of biological properties of 111In-labeled dimeric cyclic RGD peptides
AU2005254915B2 (en) Peptide-based compounds
KR20070034064A (ko) 개선된 ｎ4 킬레이트제 결합체
RU2010119187A (ru) Способ визуализации
Masuda et al. Concise site-specific synthesis of DTPA–peptide conjugates: Application to imaging probes for the chemokine receptor CXCR4
JP2011506273A5 (https=)

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20090202